Protein folding and misfolding

The manner in which a newly synthesized chain of amino acids transforms itself into a perfectly folded protein depends both on the intrinsic properties of the amino-acid sequence and on multiple contributing influences from the crowded cellular milieu. Folding and unfolding are crucial ways of regulating biological activity and targeting proteins to different cellular locations. Aggregation of misfolded proteins that escape the cellular quality-control mechanisms is a common feature of a wide range of highly debilitating and increasingly prevalent diseases.

[1]  B. Hazenberg.  Amyloidosis , 1933, The Indian medical gazette.

[2]  R. Baldwin.  Protein folding. Matching speed and stability. , 1994, Nature.

[3]  R. Baldwin.  Matching speed and stability , 1994, Nature.

[4]  A. Helenius,et al.  Quality control in the secretory pathway. , 1995, Current opinion in cell biology.

[5]  P. Pedersen,et al.  Defective protein folding as a basis of human disease. , 1995, Trends in biochemical sciences.

[6]  J. Onuchic,et al.  Navigating the folding routes , 1995, Science.

[7]  S. Prusiner,et al.  Prion diseases and the BSE crisis. , 1997, Science.

[8]  K. Dill,et al.  From Levinthal to pathways to funnels , 1997, Nature Structural Biology.

[9]  H. Roder,et al.  Kinetic role of early intermediates in protein folding. , 1997, Current opinion in structural biology.

[10]  C. Blake,et al.  The structure of amyloid fibrils by electron microscopy and X-ray diffraction. , 1997, Advances in protein chemistry.

[11]  D Eisenberg,et al.  Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly. , 1997, Advances in protein chemistry.

[12]  Bernd Bukau,et al.  The Hsp70 and Hsp60 Chaperone Machines , 1998, Cell.

[13]  M. Karplus,et al.  Protein Folding: A Perspective from Theory and Experiment. , 1998, Angewandte Chemie.

[14]  V. Muñoz,et al.  Kinetics and Dynamics of Loops, α-Helices, β-Hairpins, and Fast-Folding Proteins , 1998 .

[15]  D. Baker,et al.  Contact order, transition state placement and the refolding rates of single domain proteins. , 1998, Journal of molecular biology.

[16]  J. Kelly,et al.  The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.

[17]  C. Dobson.  Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[18]  Christopher M Dobson,et al.  From Computer Simulations to Human Disease Emerging Themes in Protein Folding , 1999, Cell.

[19]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[20]  A. R. Fresht.  Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding , 1999 .

[21]  V. Muñoz,et al.  Kinetics and Dynamics of Loops, α-Helices, β-Hairpins, and Fast-Folding Proteins , 1999 .

[22]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[23]  E. Wanker,et al.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. True,et al.  A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.

[25]  D. Baker,et al.  A surprising simplicity to protein folding , 2000, Nature.

[26]  L. Regan,et al.  A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Hecht,et al.  Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. , 2000, Journal of molecular biology.

[28]  G. Fischer,et al.  Enzymes that catalyse the restructuring of proteins. , 2000, Current opinion in structural biology.

[29]  Lorna J. Smith,et al.  Understanding protein folding via free-energy surfaces from theory and experiment. , 2000, Trends in biochemical sciences.

[30]  M. Wilson,et al.  Clusterin is a secreted mammalian chaperone. , 2000, Trends in biochemical sciences.

[31]  A. Fersht,et al.  Transition-state structure as a unifying basis in protein-folding mechanisms: contact order, chain topology, stability, and the extended nucleus mechanism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.

[33]  P. Csermely,et al.  Chaperone overload is a possible contributor to 'civilization diseases'. , 2001, Trends in genetics : TIG.

[34]  G. Kramer,et al.  Folding of a nascent peptide on the ribosome. , 2001, Progress in nucleic acid research and molecular biology.

[35]  M. Karplus,et al.  Three key residues form a critical contact network in a protein folding transition state , 2001, Nature.

[36]  A. Fersht,et al.  Rescuing the function of mutant p53 , 2001, Nature Reviews Cancer.

[37]  C. Brooks,et al.  From folding theories to folding proteins: a review and assessment of simulation studies of protein folding and unfolding. , 2001, Annual review of physical chemistry.

[38]  A. Goldberg,et al.  Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.

[39]  R. Ellis,et al.  Macromolecular crowding: an important but neglected aspect of the intracellular environment. , 2001, Current opinion in structural biology.

[40]  C. Dobson.  The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[41]  Christopher M Dobson,et al.  The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.

[42]  P. Lansbury,et al.  Neurodegenerative disease: Amyloid pores from pathogenic mutations , 2002, Nature.

[43]  Xiaohua Shen,et al.  The unfolded protein response in nutrient sensing and differentiation , 2002, Nature Reviews Molecular Cell Biology.

[44]  Christopher M. Dobson,et al.  Protein-misfolding diseases: Getting out of shape , 2002, Nature.

[45]  J. Onuchic,et al.  Protein folding mediated by solvation: Water expulsion and formation of the hydrophobic core occur after the structural collapse , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Christopher M. Dobson,et al.  Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.

[47]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[48]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[50]  Scott J. Hultgren,et al.  Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation , 2002, Science.

[51]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Raleigh,et al.  Access the most recent version at doi: 10.1110/ps.48702 References , 2000 .

[53]  F. Hartl,et al.  Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein , 2002, Science.

[54]  W. Eaton,et al.  Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy , 2002, Nature.

[55]  A. Horwich.  Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions. , 2002, The Journal of clinical investigation.

[56]  A. Fersht,et al.  Protein Folding and Unfolding at Atomic Resolution , 2002, Cell.

[57]  V. Pande,et al.  Absolute comparison of simulated and experimental protein-folding dynamics , 2002, Nature.

[58]  K. Fischbeck,et al.  Toxic Proteins in Neurodegenerative Disease , 2002, Science.

[59]  A. Macario,et al.  Sick chaperones and ageing: a perspective , 2002, Ageing Research Reviews.

[60]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[61]  Michele Vendruscolo,et al.  Protein folding and misfolding: a paradigm of self–assembly and regulation in complex biological systems , 2003, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

[62]  Kevin W Plaxco,et al.  The topomer search model: A simple, quantitative theory of two‐state protein folding kinetics , 2003, Protein science : a publication of the Protein Society.

[63]  C. Dobson,et al.  Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.

[64]  Valerie Daggett,et al.  The complete folding pathway of a protein from nanoseconds to microseconds , 2003, Nature.

[65]  Christopher M. Dobson,et al.  A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme , 2003, Nature.

[66]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[67]  C. Dobson.  Protein Folding and Disease: a view from the first Horizon Symposium , 2003, Nature Reviews Drug Discovery.

[68]  M. Karplus,et al.  Structures and relative free energies of partially folded states of proteins , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[70]  M. Kirkitadze,et al.  Amyloid b-protein (Ab) assembly: Ab40 and Ab42 oligomerize through distinct pathways , 2003 .

[71]  Martin Gruebele,et al.  Folding at the speed limit , 2003, Nature.

[72]  J. Kelly,et al.  Amyloid as a natural product , 2003, The Journal of cell biology.

[73]  T. Kiefhaber,et al.  Evidence for sequential barriers and obligatory intermediates in apparent two-state protein folding. , 2003, Journal of molecular biology.

[74]  A. Fersht,et al.  The kinetic pathway of folding of barnase. , 2003, Journal of molecular biology.